Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following November investor conferences.
Stifel 2023 Healthcare Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Wednesday, November 15, 2023 at 1:15 pm Eastern Time.
6th Annual Evercore ISI HealthCONx Conference Members of senior management will meet with investors on Wednesday, November 29, 2023.
Piper Sandler 35th Annual Healthcare Conference Dr. Coulie and Dr. Lefebvre will participate in a fireside chat on Thursday, November 30, 2023 at 9:00 am Eastern Time.
Interested parties may access the live webcasts of the Stifel and Piper Sandler fireside chats by visiting the Investors & Media page of Pliant’s website at www.PliantRx.com. Replays of the webcast will be archived on the Pliant website for 30 days following the conclusion of the events.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.